Results 61 to 70 of about 7,148 (200)
Abstract In South Korea, forest scientists refashion themselves as “climate sentinels” as they confront subtle yet disquieting shifts in plant seasonality brought about by climate change. Unlike traditional sentinels, who watch for external threats from a frontier, climate sentinels face ecological anomalies and surprises—such as untimely flowering ...
Sumin Myung
wiley +1 more source
New analysis from 15 years of Indonesian Demographic Health Survey Data has identified a shift from home birth to hospital birth. However, 65% of women who gave birth in hospital had no risk factors, while 13% of women who gave birth at home did report pregnancy‐related risk factors.
Kai Hodgkin +2 more
wiley +1 more source
Exploring medication-overuse and medication-overuse headache in cluster headache
Background It is not well established to what extent medication-overuse occurs in cluster headache (CH), if medication-overuse headache exists in CH and whether the existing criteria for medication-overuse headache are a suitable diagnostic tool in CH. We aimed to examine the prevalence of medication-overuse and
Nunu Lund +4 more
openaire +2 more sources
Novel approaches for drug development against chronic primary pain: A systematic review
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
ABSTRACT The stigma and taboo surrounding menstruation and reproductive health perpetuate a culture of silence and shame, limiting open discussions about endometriosis. Although existing research has examined its general impact on work, little attention has been paid to its influence on career‐related behaviors.
Achmet Véronique
wiley +1 more source
Background Chronic headache (headache ≥ 15 days/month for at least 3 months) affects 2–5% of the general population. Medication overuse contributes to the problem.
Kristoffersen Espen +4 more
doaj +1 more source
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Background: Chronic headache is an incapacitating condition afflicting patients at least for 15 days per month. In the most cases it is developed as a consequence of an excessive use of symptomatic drugs.
Cherubino Di Lorenzo +3 more
doaj +1 more source
Abstract Objective Evaluate early functional improvements with the preventive migraine treatment atogepant using Activity Impairment in Migraine–Diary (AIM‐D) individual and activity limitation items, and complete improvement in AIM‐D Performance of Daily Activities (PDA) and Physical Impairment (PI) domain scores assessed weekly during the first 4 ...
Richard B. Lipton +9 more
wiley +1 more source
Medication-overuse headache (MOH) was first described in 1951 with ergotamine overuse. Since then, much has been studied about its risk factors, pathophysiology, prevention, and treatment. Despite this, many people still suffer from this condition.
Renata Gomes Londero
doaj +1 more source

